James V. Cassella
Net Worth

Last updated:

What is James V. Cassella net worth?

The estimated net worth of Dr. James V. Cassella is at least $5,282,297 as of 15 Feb 2023. He has earned $442,777 from insider trading and has received compensation worth at least $4,839,520 in Concert Pharmaceuticals, Inc..

What is the salary of James V. Cassella?

Dr. James V. Cassella salary is $691,360 per year as Chief Devel. Officer in Concert Pharmaceuticals, Inc..

How old is James V. Cassella?

Dr. James V. Cassella is 70 years old, born in 1955.

What stocks does James V. Cassella currently own?

As insider, Dr. James V. Cassella owns shares in one company:

Company Title Shares Price per share Total value
Concert Pharmaceuticals, Inc. (CNCE) Chief Devel. Officer 173,061 $0 $0

What does Concert Pharmaceuticals, Inc. do?

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

CNCE logo
CNCE
Concert Pharmaceuticals, Inc.

James V. Cassella insider trading

Concert Pharmaceuticals, Inc.

Dr. James V. Cassella has made 9 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 3,762 units of CNCE stock worth $31,375 on 15 Feb 2023.

The largest trade he's ever made was exercising 10,582 units of CNCE stock on 17 Apr 2018. As of 15 Feb 2023 he still owns at least 173,061 units of CNCE stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 3,762 $8.34 $31,375
Sale
Common Stock 10,106 $8.35 $84,385
Sale
Common Stock 2,893 $7.25 $20,974
Sale
Common Stock 3,762 $3.09 $11,625
Sale
Common Stock 2,894 $3.19 $9,232
Sale
Common Stock 8,086 $3.28 $26,522
Sale
Common Stock 3,763 N/A N/A
Sale
Common Stock 4,354 $10.37 $45,151
Sale
Common Stock 10,582 $20.18 $213,513

Concert Pharmaceuticals key executives

Concert Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. James V. Cassella (70) Chief Devel. Officer
  • Dr. Roger D. Tung (65) Co-Founder, Chief Executive Officer, Pres & Executive Director
  • Mr. Richard H. Aldrich M.B.A., Mba (71) Co-Founder & Chairman